GlassScriptPhysician profile
Lora Andrews
NPI 1316295546
$2,864.49
in general payments reported to CMS, 2019-2025
20 companies · $506 in 2025
The $506 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $664 · 2022: $720 · 2023: $436 · 2024: $538 · 2025: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,479.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $608.33 | 2021-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $502.65 | 2021-2025 | |
| Pfizer INC. | $280.98 | 2021-2025 | |
| Amgen INC. | $225.07 | 2021-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $206.33 | 2021-2023 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $200.36 | 2021-2025 | Wainua |
| Boehringer Ingelheim Pharmaceuticals, INC. | $199.18 | 2021-2025 | Jardiance |
| Alnylam Pharmaceuticals INC. | $114.82 | 2024-2025 | Onpattro |
| Actelion Pharmaceuticals US, INC. | $100.04 | 2023-2024 | Opsumit, Uptravi |
| Boston Scientific Corporation | $94.22 | 2021-2023 | Watchman Access System |
| Philips North America LLC | $69.80 | 2022 | |
| Kestra Medical Technology Services, INC. | $68.68 | 2022-2023 | Assure Wcd |
| Bayer Healthcare Pharmaceuticals INC. | $42.94 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $36.00 | 2021 | |
| Janssen Pharmaceuticals, INC | $27.93 | 2023 | Xarelto |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $22.53 | 2024 | Camzyos |
| Vital Connect, INC | $17.96 | 2025 | Vitalpatch Rtm |
| Cleerly, INC. | $17.53 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Abbott Laboratories | $14.88 | 2021 | |
| Glaxosmithkline, LLC. | $14.26 | 2025 | Shingrix, Arexvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lora Andrews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.